Human Papillomavirus (HPV) Vaccine Market Size, Share & COVID-19 Impact Analysis, By Type (Bivalent and Polyvalent), By Disease Indication (HPV Associated Cancer and Genital Warts), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others) and Geography Forecast, 2020-2027

 ATTRIBUTE

  DETAILS

Study Period

  2016-2027

Base Year

  2019

Forecast Period

  2020-2027

Historical Period

  2016-2018

Unit

  Value (USD billion)

Segmentation

By Type

• Bivalent


• Polyvalent

By Disease Indication

• HPV Related Cancer


• Gential Warts

By Distribution Channel

• Hospital & Retail Pharmacies


• Government Suppliers


• Others

By Geography

• North America (U.S. and Canada)


• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)


• Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)


• Latin America (Brazil, Mexico, and Rest of Latin America)


• Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)